A case of McCune-Albright syndrome associated with pituitary GH adenoma: Therapeutic process and autopsy

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 5-6, 2011, Pages 283-287

  Liu, Fuyi ^a   Li, Wenting ^b   Yao, Yong ^c   Li, Guilin ^c   Yang, Yi ^c   Dou, Wanchen ^c   Zhong, Dingrong ^c   Wang, Lin ^a   Zhu, Xiangdong ^a   Hu, Hua ^a   Zhang, Jianmin ^a   Wang, Renzhi ^c   Chen, Gao ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

McCune Albright syndrome; papillary carcinoma of the thyroid gland; pituitary GH adenoma; radiation therapy

Indexed keywords

GROWTH HORMONE;

ADULT; ALBRIGHT SYNDROME; ARTICLE; AUTOPSY; BRAIN DEATH; BRAIN HERNIA; CANCER RADIOTHERAPY; CASE REPORT; CHONDROSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FIBROUS DYSPLASIA; FOLLOW UP; GROWTH HORMONE RELEASE; HEARING LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; LUNG INSUFFICIENCY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RARE DISEASE; THYROID PAPILLARY CARCINOMA;

ACROMEGALY; ADENOMA; ADULT; AUTOPSY; BONE NEOPLASMS; CHONDROSARCOMA; FATAL OUTCOME; FIBROUS DYSPLASIA, POLYOSTOTIC; GIGANTISM; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; MALE; NEOPLASMS, RADIATION-INDUCED;

EID: 79959412143     PISSN: 0334018X     EISSN: 0334018X     Source Type: Journal    
DOI: 10.1515/JPEM.2011.178     Document Type: Article

References (21)

1. Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, et al. Characterization of GSP-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 2002;87:5104-12. (Pubitemid 35316352)
2. Ringel MD, Schwindinger WF, Levine MA. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine (Baltimore) 1996;75:171-84. (Pubitemid 26260235)
3. Dou W, Lin N, Ma W, Yang Y, Zhu H, et al. Transsphenoidal surgery in a patient with acromegaly and McCune-Albright syndrome: application of neuronavigation. J Neurosurg 2008;108:164-9.
4. Chanson P, Dib A, Visot A, Derome PJ. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol 1994;131:229-34. (Pubitemid 24297510)
5. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer 1994;73:1411-24. (Pubitemid 24072547)
6. Galland F, Kamenicky P, Affres H, Reznik Y, Pontvert D, et al. McCune-Albright syndrome and acromegaly: effects of hypotha-lamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J Clin Endocrinol Metab 2006;91:4957-61. (Pubitemid 44917334)
7. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 2001;22:675-705. (Pubitemid 32955250)
8. Sheppard DG, Libshitz HI. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol 2001;56:22-9. (Pubitemid 32685180)
9. Hansen MR, Moffat JC. Osteosarcoma of the skull base after radiation therapy in a patient with McCune-Albright syndrome: case report. Skull Base 2003;13:79-83. (Pubitemid 36798541)
10. Kaushik S, Smoker WR, Frable WJ. Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma. Skeletal Radiol 2002;31:103-6. (Pubitemid 36067517)
11. Mortensen A, Bojsen-Moller M, Rasmussen P. Fibrous dyspla-sia of the skull with acromegaly and sarcomatous transformation. Two cases with a review of the literature. J Neurooncol 1989;7:25-9.
12. Park SW, Kim HJ, Lee JH, Ko YH. Malignant fibrous histiocy-toma of the head and neck: CT and MR imaging findings. Am J Neuroradiol 2009;30:71-6.
13. Hoshi M, Matsumoto S, Manabe J, Tanizawa T, Shigemitsu T, et al. Malignant change secondary to fibrous dysplasia. Int J Clin Oncol 2006;11:229-35. (Pubitemid 44087122)
14. Ohmori K, Matsui H, Kanamori M, Yudoh K, Yasuda T, et al. Malignant fibrous histiocytoma secondary to fibrous dysplasia. A case report. Int Orthop 1996;20:385-8.
15. Amin R, Ling R. Case report: malignant fibrous histiocytoma following radiation therapy of fibrous dysplasia. Br J Radiol 1995;68:1119-22.
16. Cheng MH, Chen YR. Malignant fibrous histiocytoma degeneration in a patient with facial fibrous dysplasia. Ann Plast Surg 1997;39:638-42.
17. Cremonini N, Graziano E, Chiarini V, Sforza A, Zampa GA. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995-bromocriptine combined treatment results. J Clin Endocrinol Metab 1992;75:1166-9.
18. Sakaki S, Yokoyama S, Mamitsuka K, Nakayama M, Goto M, et al. A case of pituitary adenoma associated with McCune-Albright syndrome. Pituitary 1999;1:297-302.
19. Feuillan PP, Jones J, Ross JL. Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 1995;80:1357-60.
20. Celi FS, Coppotelli G, Chidakel A, Kelly M, Brillante BA, et al. The role of type 1 and type 2 5'-deiodinase in the pathophysiol-ogy of the 3, 5, 3'-triiodothyronine toxicosis of McCune-Albright syndrome. J Clin Endocrinol Metab 2008;93:2383-9. (Pubitemid 351831562)
21. Collins MT, Sarlis NJ, Merino MJ, Monroe J, Crawford SE, et al. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab 2003;88:4413-7. (Pubitemid 37153751)